Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 25 Jul 2025 – 20 Aug 2026, limited by Nippon India MNC Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Nippon India MNC Fund | Nifty 500 |
|---|---|---|
| 25 Jul 2025 | ₹100.00 | ₹100.00 |
| 27 Aug 2025 | ₹103.61 | ₹98.93 |
| 28 Sep 2025 | ₹105.68 | ₹98.69 |
| 31 Oct 2025 | ₹108.69 | ₹103.02 |
| 02 Dec 2025 | ₹109.89 | ₹103.51 |
| 04 Jan 2026 | ₹110.14 | ₹104.71 |
| 06 Feb 2026 | ₹106.87 | ₹101.82 |
| 10 Mar 2026 | ₹104.46 | ₹97.08 |
| 12 Apr 2026 | ₹102.50 | ₹97.10 |
| 14 May 2026 | ₹105.48 | ₹98.25 |
| 16 Jun 2026 | ₹107.84 | ₹99.92 |
| 18 Jul 2026 | ₹108.11 | ₹101.40 |
| 20 Aug 2026 | ₹111.25 | ₹102.16 |
| Metric | Nippon India · Regular NAV ₹10.97 Very High risk ★★★☆☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +6.59% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +10.47% | +12.26% | |
| +8.27% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 12.72% | 15.62% | |
| 0.01 | 0.43 | |
| 0.01 | 0.59 | |
| -13.39% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 2.54% | 2.39% | |
| ₹419.06Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹500 | — | |
| — | 45% | |
| Kinjal Desai · 1.1y | — | |
| 25 Jul 2025 | — | |
| 35 | — | |
| 55.9% | — | |
| 2.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.